Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Creuzot CherylDirector | Grant or award | A | — 2,250 sh | May 28, 2026 |
| 16 | Wahlman Robert E.EVP, Chief Financial Officer | Tax withholding | F | $55K 3,918 sh | May 28, 2026 traded May 27, 2026 |
| 15 | Chakravarthy ArthiChief Legal Officer | Tax withholding | F | $15K 2,221 sh | May 28, 2026 traded May 24, 2026 |
| 13 | Musser ForySenior VP, Development | Option exercise | M | — 233.7K sh | May 28, 2026 traded May 27, 2026 |
| 13 | Sharir KerenPresident | Option exercise | M | $30K 4,500 sh | May 28, 2026 traded May 27, 2026 |
| 13 | Mudick Stephanie BDirector | Grant or award | A | — 3,600 sh | May 28, 2026 traded May 27, 2026 |
| 13 | Singh VikasEVP & Chief Financial Officer | Option exercise | M | $19K 935 sh | May 28, 2026 traded May 27, 2026 |
| 13 | Alvarez Divo Carlos EduardoDirector | Open-market sale · 10b5-1 plan | SELL | $11K 10.0K sh | May 28, 2026 traded May 15, 2026 |
| 13 | Duchemin-Leslie NadineDirector | Grant or award | A | — 4,012 sh | May 28, 2026 traded May 26, 2026 |
| 13 | Blomquist Denise L.Chief Accounting Officer | Option exercise | M | — 1,712 sh | May 28, 2026 traded May 26, 2026 |
| 13 | Pfeifer ThomasExecutive Vice President | Grant or award | A | — 8,010 sh | May 28, 2026 traded May 26, 2026 |
| 13 | Metzfield DennisVP, PAO & Controller | Grant or award | A | — 1,642 sh | May 28, 2026 traded May 26, 2026 |
| 13 | Simmons Kurt JRDirector | Grant or award | A | $40K 1,969 sh | May 28, 2026 traded May 26, 2026 |
| 13 | Earl ThomasChief Commercial Officer | Option exercise | M | — 1.00M sh | May 28, 2026 traded May 27, 2026 |
| 13 | Tabak ShawnCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $303K 30.0K sh | May 28, 2026 traded May 26, 2026 |
| 13 | Musser ForySenior VP, Development | Option exercise | M | — 266.3K sh | May 28, 2026 traded May 26, 2026 |
| 12 | Sousa Mauad BrunoDirector | Other acquisition or disposition | J | — 200 sh | May 28, 2026 traded May 26, 2026 |
| 12 | Sousa Mauad BrunoDirector | Other acquisition or disposition | J | — 200 sh | May 28, 2026 traded May 26, 2026 |
| 11 | Earl ThomasChief Commercial Officer | Option exercise | M | $790K 1.00M sh | May 28, 2026 traded May 27, 2026 |
| 11 | Whalen Thomas GerardDirector | Grant or award · 10b5-1 plan | A | $40K 1,969 sh | May 28, 2026 traded May 26, 2026 |
| 10 | Fruhbeis Todd MichaelDirector | Grant or award | A | — 5,504 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Lamb William HDirector | Grant or award | A | — 2,250 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Albright Craig MorrowEVP, Chief Financial Officer | Grant or award | A | — 16.1K sh | May 28, 2026 traded May 27, 2026 |
| 9 | Arias Juan CarlosSee Remarks | Tax withholding | F | $4,872 348 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Blomquist Denise L.Chief Accounting Officer | Option exercise | M | — 1,621 sh | May 28, 2026 traded May 26, 2026 |
| 9 | McEntee James J IIIDirector | Grant or award | A | — 3,600 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Seger Brett A.Chief Accounting Officer | Tax withholding | F | $1,647 230 sh | May 28, 2026 traded May 28, 2026 |
| 9 | Long Darren MarcVice President | Option exercise | M | — 8,675 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Morrell MarthaCHIEF MEDICAL OFFICER | Tax withholding | F | $6,107 358 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Bell John IrvingDirector | Grant or award | A | — 27.5K sh | May 28, 2026 traded May 27, 2026 |
| 9 | Marinaro MichaelEVP, Pres MedSurg and Americas | Option exercise | M | — 17.1K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Kozlov HershDirector | Grant or award | A | — 3,600 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Maurer Michael TCHIEF COMMERCIAL OFFICER | Grant or award | A | — 80.0K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Llewellyn Lindsay CatherineSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $157K 11.5K sh | May 28, 2026 traded May 26, 2026 |
| 9 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | Open-market sale · 10b5-1 plan | SELL | $292K 1,438 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $335K 1,652 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Weber AndrewEVP, Technology and Operations | Grant or award | A | — 11.9K sh | May 28, 2026 traded May 27, 2026 |
| 9 | Chapman Jeffrey MDirector | Grant or award | A | — 1,532 sh | May 28, 2026 traded May 26, 2026 |
| 9 | Clayton Natasha LauretteSee Remarks | Tax withholding | F | $27K 1,961 sh | May 28, 2026 traded May 27, 2026 |
| 9 | Walter Matthew R.SVP, Chief HR Officer | Option exercise | M | — 8,449 sh | May 28, 2026 traded May 26, 2026 |